Stocktoria
EBOS Group Limited EBO.NZ
EBOS Group Limited (EBO.NZ) earns a Piotroski F-score of 4/9 (mixed financial health), with an Altman Z″ in the grey zone. It pays a dividend yielding 3.43% (safety: stretched). FY2025 revenue was A$13.2B at a 1.8% net margin.
Price from month-end closes (Yahoo) — for reference, not real-time.
How it ranks in Healthcare · percentile among 36 companies
Percentile vs other Healthcare companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 4/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · grey zone
| Component | Value |
|---|---|
| Working capital / assets | 0.065 |
| Retained earnings / assets | 0.069 |
| EBIT / assets | 0.058 |
| Equity / liabilities | 0.602 |
FAQ
Is EBO.NZ financially healthy?
EBOS Group Limited's Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the grey zone.
Does EBO.NZ pay a dividend, and is it safe?
Yes. EBOS Group Limited pays a dividend yielding about 3.43% with a 63.7% payout ratio, rated “stretched” for safety.
How profitable is EBO.NZ?
In FY2025, EBOS Group Limited had a net margin of 1.8% and a return on equity of 7.9%.
Source: company filings via Yahoo Finance · NZ · as of 2025-06-30. Figures in AUD; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.